Literature DB >> 6247125

The significance of the signet-cell variety of adenocarcinoma of the rectum.

J C Bonello, S S Sternberg, S H Quan.   

Abstract

Seventeen cases of signet-cell mucinous adenocarcinoma of the rectosigmoid and rectum, seen over a 25-year period at Memorial Sloan-Kettering Hospital, were reviewed. We conclude, in agreement with previous authors, that it is an infrequent lesion that is usually discovered at an advanced stage. However, with early radical surgical intervention the prognosis can be favorable.

Entities:  

Mesh：

Year:  1980        PMID： 6247125     DOI： 10.1007/bf02587622

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Mixed crypt cell carcinoma. A clinicopathological study of the so-called 'goblet cell carcinoid'.

Authors:  P H Watson; A Alguacil-Garcia
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Linitis plastica of the alimentary tract and scrotum.

Authors:  A H Zalev; J P Baker; G W Gardiner
Journal:  Gastrointest Radiol       Date:  1990

3.  Detection of early neoplastic changes in experimentally induced colorectal cancer using scanning electron microscopy and cell kinetic studies.

Authors:  T Cooke; N Kirkham; D H Stainthorp; C Inman; N Goeting; I Taylor
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Primary signet-ring cell carcinoma of the colorectum.

Authors:  Birgit Bittorf; Susanne Merkel; Klaus E Matzel; Axel Wein; Arno Dimmler; Werner Hohenberger
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

5.  A case of linitis plastica of the rectum treated by pelvic exenteration after aggressive immunochemotherapy.

Authors:  S Sato; K Iwasaki; M Torisu
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Primary signet-ring cell carcinoma of the colon and rectum.

Authors:  T Anthony; R George; M Rodriguez-Bigas; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.